PD Dr. med. Sabine Ohlmeyer MHBA
Dr. Sabine Ohlmeyer
Projektleitung C3
Uniklinikum Erlangen
MR biosignatures as a guide for stratification for breast cancer risk assessment
- E-Mail: sabine.ohlmeyer@uk-erlangen.de